Follow Us On

Facebook  X  Linkedin  YouTube
 
 

Time to Submit Comment

Letters to CMS and Congress!


CMS has issued two proposed rules that will set 2027 Medicare payment for interventional pain management: the CY 2027 Physician Fee Schedule and the CY 2027 OPPS/ASC Payment System. ASIPP is commenting on both. We ask that every State Society also file its own separate comment letter. Letters from societies across the country show CMS the nationwide impact on physicians, independent practices, ASCs, and Medicare patients.


Here are links to two sample letters:

Comment Deadline is August 31, 2026

Comment Deadline is September 14, 2026

INSTRUCTIONS FOR OPENING LETTERS

When you click on the sample letter links, the letters will automatically download to your Downloads folder.


Please use them as a starting point, not as a form.

Identical letters carry little weight with CMS. We ask you to rewrite using your own letterhead, change the wording and order, add state-specific examples, and keep ASIPP’s key issues and requests.

 

Please also write to Congress. Send letters to both of your U.S. Senators and to one member of your U.S. House delegation, asking for an annual inflation update to Medicare physician payment and relief from budget neutrality.


Click here for Senator contact information.

Click here for Representative contact information.

 

The OPPS/ASC deadline is less than two weeks away. Please act now.


Thank you for your continued support and advocacy on behalf of ASIPP and Medicare beneficiaries.

Medicare Improperly Paid Physicians an Estimated $15.2 Million for Sacroiliac Joint Injections 


This nationwide audit was conducted to determine whether Medicare paid physicians for sacroiliac joint injections in accordance with Medicare requirements and guidance. OIG found that of the 100 sampled sessions, 72 did not comply with Medicare requirements.


In addition, of the 100 sampled sessions, physicians’ billing for 25 sessions did not meet Medicare guidance. Based on OIG sample results, it is estimated that Medicare improperly paid $15.2 million for 134,526 of 186,842 total sessions from October 1, 2023, through September 30, 2024.

 

Why OIG Did This Audit

  • Sacroiliac joint injections (a type of spinal pain management service) are covered under Medicare Part B when medically reasonable and necessary.


  • In two prior audits of facet-joint interventions (another type of spinal pain management service), OIG found that Medicare paid for more than 50 percent of the sampled services that did not comply with one or more Medicare requirements.


  • Because OIG identified a high risk of noncompliance with facet-joint interventions, they conducted this nationwide audit to determine whether Medicare paid physicians for sacroiliac joint injections in accordance with Medicare requirements and guidance.


Click here to read the full report.

 

ASIPP has submitted a proposal to the Centers for Medicare & Medicaid Services (CMS) proposing the creation of an Independent Physician Payment Modifier under Medicare.


The proposal is intended to help preserve independent physician practices by establishing a modifier that would identify qualifying independent physicians and provide a 10% payment adjustment for eligible physician services, while maintaining budget neutrality and protecting existing facility payments.


Click here to view ASIPP’s Letter to Joseph Albanese, CMS/CM


Click here to view ASIPP’s Proposed Modifier for Independent Physician Services

 

Ready to build your practical skills?


Join ASIPP in Memphis on August 28–29 for hands-on workshops in Ultrasound for Regenerative Medicine, Regenerative Medicine, and Interventional Techniques in IPM.


Also offering a $200 PNS workshop and a $100 introduction to the VIA Disc NP procedure.


Space is limited for these workshops. Early registration is encouraged.


Click here to learn more.

WORKSHOP ACCOMMODATIONS

The Westin Memphis, Beale Street

170 Lt. George W Lee Ave

Memphis, TN 38103

901-334-5900



Click Here to Reserve Your Room


Thank you to everyone who joined our highly

successful Peripheral Nerve Stimulation webinar!


Click here to watch the webinar recording.


We invite you to continue your educational experience

by joining us at the $200 PNS Hands-On Workshop.

FRIDAY, AUGUST 28



Ultrasound for Regenerative Medicine Hands-On Workshop



Earn 8 CMEs while gaining practical ultrasound experience focused on regenerative medicine applications.


Interested in intradiscal therapy?


Click here to watch the recording of ASIPP's Current Advances in Intradiscal Therapy webinar to explore expert insights.

Then join us in Memphis on Saturday, August 29 for an Introduction to the VIA Disc Nucleus Pulposus Allograft Procedure for $100.

Interested in advancing your knowledge of REGENERATIVE MEDICINE?


Watch the recording of ASIPP's complimentary webinar,

Current Advances and Future Directions of Regenerative Medicine,

to explore the topics and insights you can receive during our Hands-On Workshop.


Click here to watch the webinar recording.


Then take the next step and join us in

Memphis on August 29 for expert, hands-on instruction.

SATURDAY, AUGUST 29



Regenerative Medicine Hands-On Cadaver Workshop

(Basic, Intermediate, & Advanced)



Earn 8 CMEs in this cadaver workshop with hands-on instruction covering regenerative medicine techniques across varying experience levels.

SATURDAY, AUGUST 29



Interventional Techniques in IPM Hands-On Cadaver Workshop

(Basic, Intermediate & PNS)


Earn 8 CMEs in this workshop focused on interventional pain management techniques and peripheral nerve stimulation applications.

CMS has released the CY 2027 Medicare Physician Fee Schedule Proposed Rule (CMS-1848-P). The overall picture is unfavorable: CMS estimates a combined -2% impact on interventional pain management, with additional proposals affecting E/M billing, MIPS, and imaging/laboratory payment. Two documents are attached — the proposed rule and ASIPP’s code-by-code payment comparison for 2027 vs. 2026. Key points below.

 

Conversion Factor: Proposed Cut

With the one-year 2.5% statutory increase for 2026 expiring, CMS proposes:

  • Qualifying APM participants: $33.17, down from $33.57 (-1.19%)
  • All other clinicians (non-QP): $32.84, down from $33.40 (-1.68%)

These figures reflect a +0.53% budget-neutrality adjustment and statutory updates of +0.75% (QP) and +0.25% (non-QP). They do not include the 2% sequester or potential 4% PAYGO cuts.

 

IPM Codes: Widespread Reductions vs. 2026

Most interventional pain codes are cut 1–6% in the office setting and 1-4% in Facility:

Office Setting

Facility Setting

Epidurals

(62321 & 62323)

-3.0% to -3.3%

-2.7% to -3.0%

Transforaminal

(64479 to 64484)

-3.7% to -4.9%

-1.2% to -3.8%

Facet joint

(64490-64495)

-1.3% to -3.5%

-1.2% to -3.6%

Radiofrequency Ablation (64633-36)

-4.9% to -5.2%

-1.2% to -3.3%

SCS Lead Placement (63650)

-5.9%

-3.0%

EM Services

(99203-205, 213-215)

1.4% to -3.8%

-1.2% to -2.5%

  • Trigeminal nerve injection (64400): -19.9%; greater occipital nerve (64405): -16.6%
  • Percutaneous SI joint fusion (27279, facility): -14.9%
  • Kyphoplasty (22513–22515): -6.0% to -6.1%
  • Spinal cord stimulator trial (63650): -5.9%; percutaneous
  • PNS (64555): -6.3%


A handful of codes see small increases (e.g., blood patch 62273, several peripheral nerve blocks). The attached table shows every IPM code.


E/M Services: Major Change to Modifier -25

CMS proposes that when a separately identifiable office E/M visit is billed with modifier -25 on the same day as a 0-, 10-, or 90-day global procedure, only the highest-paid service is paid at 100% — all others, including the E/M visit, are cut 50%. This directly targets the common office-based scenario of a same-day evaluation and injection. CMS also proposes replacing add-on code G2211 with modifier MOD1, valued at 16% of the base E/M code (32% for ACO participants via MOD2). E/M payment rates themselves decline modestly (see attached table).


MIPS / Quality Payment Program

  • Traditional MIPS would sunset with the CY 2029 performance period (2031 payment year), making MIPS Value Pathways (MVPs) the sole reporting option; three new MVPs are proposed.
  • The quality measure inventory would be set at 180 measures (20 removals, 10 additions), with a new MIPS core measure reporting requirement replacing the outcome/high-priority measure requirement (small practices exempt).
  • The performance threshold remains 75 points. Separately, the rule proposes refinements to the Ambulatory Specialty Model (ASM), the mandatory model whose low back pain cohort includes interventional pain physicians.


RFI: Duplicate Laboratory Testing, Imaging, and Interoperability

CMS is seeking input on mechanisms to address duplicate laboratory and imaging tests, including MAC edits resulting in non-payment or reduced payment, recoupment of payments, frequency limitations, and revised billing instructions, along with improved result sharing and interoperability. These policies could significantly affect pain practices that rely on imaging and drug testing. ASIPP will submit detailed comments — please send us your input.


Act Now

Comments are due September 14, 2026 (file code CMS-1848-P). Please review the attached documents and send your feedback to asipp@asipp.org so we can represent you forcefully. ASIPP will fight these cuts, as we always have — but your voice makes the difference.


View the CY 2027 PFS Proposed Rule Fact Sheet


View the ASIPP 2027 vs. 2026 Proposed Payment Rate Comparison for IPM Codes

 

SAVE THE DATE - APRIL 15-17, 2027

Save the date for the American Society of Interventional Pain Physicians' 29th Annual Meeting, April 15 - 17, 2027, in Orlando, Florida.


This flagship educational event will bring together physicians, researchers, and healthcare professionals from across the country for three days of cutting-edge education, collaboration, and professional networking.


Attendees can look forward to our most comprehensive Annual Meeting yet, featuring new educational topics, expanded faculty participation, and innovative program enhancements designed to keep you at the forefront of interventional pain management.


Mark your calendar now and plan to join us in Orlando as we continue advancing excellence in interventional pain management. Additional program details and faculty announcements will be released soon.


Register by October 1, 2026, to receive a 10% Early Bird Discount.

Study Questions How Prostate Cancer Focal Therapy Is Being Used

Half of procedures occurred in settings not supported by guidelines

 

Key Takeaways


• Current guidelines recommend that focal therapy be reserved for patients with intermediate-risk prostate cancer within clinical trials or prospective registries.


• In a retrospective study, half of focal therapy procedures were done in patients with low-, high-, or very-high-risk prostate cancer.


• Focal therapy for low- and high-risk disease represents overtreatment and undertreatment, respectively

While the use of focal therapy for nonmetastatic prostate cancer is limited, half of procedures occurred in settings that are not supported by current guidelines, according to a retrospective study.


Among over 1.1 million men diagnosed with nonmetastatic prostate cancer from 2010 to 2023, 1.3% received focal therapy, and 51% of these patients had low-, high-, or very-high-risk disease, "settings in which routine use is not supported by contemporary guidelines," reported Quoc-Dien Trinh, MD, of the University of Pittsburgh School of Medicine, and colleagues in a research letter in JAMA.


Click here to read the full article.

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.



What's Going on With Fall COVID and Flu Shots? 

A key federal advisory committee hasn't weighed in




By this time of year, both the FDA and CDC normally have weighed in on fall respiratory virus vaccine recommendations. But given ongoing controversies over vaccination spurred by the Trump administration, a wrench has once again been thrown into the gears of that process.


The FDA has done its part, making recommendations about vaccine composition for influenza vaccines in March, followed by recommendations for COVID shots in May. But the CDC's Advisory Committee on Immunization Practices (ACIP) hasn't done its part as it hasn't held its March or June meetings this year.


Typically, after the FDA meets, ACIP "then meets and makes recommendations about how to use those vaccines," David Freedman, MD, professor emeritus of infectious diseases at the University of Alabama at Birmingham and spokesperson for the Infectious Diseases Society of America (IDSA), told Medpage Today.


Click here to read the full article.

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


No additional cost for ASIPP members!

Watchdog Urges HHS to Investigate Conflicts Among FDA's Peptide Panelists 

Several members seem to have "disqualifying financial interests," consumer group says



A consumer watchdog group is demanding that the HHS Office of Inspector General (OIG) look into potential conflicts of interest among members of an FDA advisory committee that recommended that six peptides be added to the list of substances that can be compounded, despite a lack of evidence of their efficacy.


"Several members of the 2026 Pharmacy Compounding Advisory Committee (PCAC) appear to have had disqualifying financial interests in the pharmaceutical and peptide industries at the time of the July 23-24, 2026, meeting related to peptide therapies," Kedric Payne, vice president and general counsel at the Campaign Legal Center, and Margaret Dylus-Yukins, the group's senior legal counsel for ethics, wrote last week in a letter to HHS Inspector General T. March Bell.


"Despite publicly available information to the contrary, the FDA Office of Ethics and Integrity (OEI) found that none of the 2026 PCAC members had any conflicts of interest and allowed them to participate in the meeting without ethics waivers," they added. "The Campaign Legal Center asks that HHS OIG investigate FDA OEI's ethics decisions and determine if the 2026 PCAC members violated criminal ethics laws by participating in the meeting without waivers in place."


Click here to read the full article.


Apply now for one of the following 2026 dates:



October 24, November 14,

& December 12



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates

Our Sponsor

Our Sponsor

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Novel Use of Temporary Percutaneous Peripheral Nerve Stimulation for Middle Cluneal Neuralgia: A Case Report


Rohan Gogoi, MD, Maximos Bogdady, DO, Saiyid Mahmood, MD, Marco Lawandy, DO, and Kevin Sperber, MD

Managing Erythromelalgia-Associated Pain with Suzetrigine: A Case Report


Don Hoang, MD, Jennifer Hubbell, DNP, and Thomas Verbeek, MMed

Diagnostic Role of Celiac Plexus Block in Assessing Eligibility for Corrective Surgery in a Case of Median Arcuate Ligament Syndrome


Syama Sundar Ayya, DM, Anish Waghray, DNB, Sandeep Garre, DM, Rama Krishna Prasad, MD, Aniruth Chand Anna C, MBBS, and Kalyani Surya Dhana Lakshmi Sangineni, MD.

 

New Issue Now Available!

 
 

RANDOMIZED TRIAL

Modulation of Pain Perception Through Identifying Emotionally with Music Feedback During Physical Exercise for Patients with Chronic Pain: A Randomized Trial


Lydia Schneider, MSc, Cornelia Exner, PhD, Alida Wulfson, N/A, Jutta Geidel, N/A, Michael Schenk, MD, and Thomas Hans Fritz, PhD

RANDOMIZED CONTROLLED TRIALS

Dual Stellate Ganglion Blocks for Managing Treatment-Resistant Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial


G Niraj, Varsha Karanth, N Charan, Shruti Niraj, A Aiswarya, and Paul Bassett

The Efficacy and Safety of Pregabalin Combined with Venlafaxine in Fibromyalgia Patients: Protocol for a Prospective, Randomized, Open-Label, Blinded-Endpoint Trial


Minying Liu, Ruilin He, Likui Wang, Jian Cui, Daying Zhang, Bifa Fan, Fang Luo, and Shuiqing Li




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!